BGIM
Brandywine Global Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-95,740
| Closed | -$69.1M | – | 751 |
|
|
2022
Q4 | $69.1M | Buy |
95,740
+8,191
| +9% | +$5.91M | 0.54% | 43 |
|
|
2022
Q3 | $60.3M | Sell |
87,549
-2,203
| -2% | -$1.52M | 0.56% | 44 |
|
|
2022
Q2 | $53.1M | Sell |
89,752
-3,581
| -4% | -$2.12M | 0.46% | 61 |
|
|
2022
Q1 | $65.2M | Sell |
93,333
-3,327
| -3% | -$2.32M | 0.48% | 52 |
|
|
2021
Q4 | $61M | Sell |
96,660
-10,656
| -10% | -$6.73M | 0.44% | 58 |
|
|
2021
Q3 | $64.9M | Buy |
107,316
+39,126
| +57% | +$23.7M | 0.49% | 47 |
|
|
2021
Q2 | $38.1M | Buy |
68,190
+10,745
| +19% | +$6M | 0.28% | 89 |
|
|
2021
Q1 | $27.2M | Sell |
57,445
-66,521
| -54% | -$31.5M | 0.2% | 131 |
|
|
2020
Q4 | $59.9M | Buy |
123,966
+107,945
| +674% | +$52.1M | 0.5% | 43 |
|
|
2020
Q3 | $8.97M | Buy |
+16,021
| New | +$8.97M | 0.09% | 213 |
|